The present invention relates to a compound, the compound is a compound represented by a formula (I), or an isomer, an
isotope derivative, a polymorphic substance, a
prodrug, a pharmaceutically acceptable salt or a solvate thereof, and the definitions of A1, B1 and L are the same as the definitions in the specification. Also provided are pharmaceutical compositions and compounds of formula (I) for use in methods of treating related diseases by inhibition of MAT2A, including some cancers in which a
gene encoding a
methylthioadenosine phosphorylase (MTAP) is deleted and / or not fully functioning.